1-9 of 9
P. Andrew Futreal
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Correction: Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets

Renata Ferrarotto, Yoshitsugu Mitani, Daniel J. McGrail, Kaiyi Li, Tatiana V. Karpinets, Diana Bell, Steven J. Frank, Xingzhi Song, Michael E. Kupferman, Bin Liu, J. Jack Lee, Bonnie S. Glisson, Jianhua Zhang, Jon C. Aster, Shiaw-Yih Lin, P. Andrew Futreal, John V. Heymach, Adel K. El-Naggar
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (14): 2737.
https://doi.org/10.1158/1078-0432.CCR-23-1697
Published: 14 July 2023
View article titled, Correction: Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets
Open the PDF for Correction: Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets in another window
Journal Articles

Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets

Renata Ferrarotto, Yoshitsugu Mitani, Daniel J. McGrail, Kaiyi Li, Tatiana V. Karpinets, Diana Bell, Steven J. Frank, Xingzhi Song, Michael E. Kupferman, Bin Liu, J. Jack Lee, Bonnie S. Glisson, Jianhua Zhang, Jon C. Aster, Shiaw-Yih Lin, P. Andrew Futreal, John V. Heymach, Adel K. El-Naggar
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2021) 27 (3): 852–864.
https://doi.org/10.1158/1078-0432.CCR-20-1192
Published: 01 February 2023
View article titled, Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets
Open the PDF for Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets in another window
Includes: Supplementary data
Journal Articles

Evolution of Genomic and T-cell Repertoire Heterogeneity of Malignant Pleural Mesothelioma Under Dasatinib Treatment

Runzhe Chen, Won-Chul Lee, Junya Fujimoto, Jun Li, Xin Hu, Reza Mehran, David Rice, Stephen G. Swisher, Boris Sepesi, Hai T. Tran, Chi-Wan Chow, Latasha D. Little, Curtis Gumbs, Cara Haymaker, John V. Heymach, Ignacio I. Wistuba, J. Jack Lee, P. Andrew Futreal, Jianhua Zhang, Alexandre Reuben, Anne S. Tsao, Jianjun Zhang
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (20): 5477–5486.
https://doi.org/10.1158/1078-0432.CCR-20-1767
Published: 15 October 2020
View article titled, Evolution of Genomic and T-cell Repertoire Heterogeneity of Malignant Pleural Mesothelioma Under Dasatinib Treatment
Open the PDF for Evolution of Genomic and T-cell Repertoire Heterogeneity of Malignant Pleural Mesothelioma Under Dasatinib Treatment in another window
Includes: Supplementary data
Journal Articles

Multifactorial Deep Learning Reveals Pan-Cancer Genomic Tumor Clusters with Distinct Immunogenomic Landscape and Response to Immunotherapy

Feng Xie, Jianjun Zhang, Jiayin Wang, Alexandre Reuben, Wei Xu, Xin Yi, Frederick S. Varn, Yongsheng Ye, Junwen Cheng, Miao Yu, Yue Wang, Yufeng Liu, Mingchao Xie, Peng Du, Ke Ma, Xin Ma, Penghui Zhou, Shengli Yang, Yaobing Chen, Guoping Wang, Xuefeng Xia, Zhongxing Liao, John V. Heymach, Ignacio I. Wistuba, P. Andrew Futreal, Kai Ye, Chao Cheng, Tian Xia
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (12): 2908–2920.
https://doi.org/10.1158/1078-0432.CCR-19-1744
Published: 15 June 2020
View article titled, Multifactorial Deep Learning Reveals Pan-Cancer Genomic Tumor Clusters with Distinct Immunogenomic Landscape and Response to Immunotherapy
Open the PDF for Multifactorial Deep Learning Reveals Pan-Cancer Genomic Tumor Clusters with Distinct Immunogenomic Landscape and Response to Immunotherapy in another window
Includes: Supplementary data
Journal Articles

The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine Carcinoma

Minglei Zhuo, Yanfang Guan, Xue Yang, Lingzhi Hong, Yuqi Wang, Zhongwu Li, Runzhe Chen, Hussein A. Abbas, Lianpeng Chang, Yuhua Gong, Nan Wu, Jia Zhong, Wenting Chen, Hanxiao Chen, Zhi Dong, Xiang Zhu, Jianjie Li, Yuyan Wang, Tongtong An, Meina Wu, Ziping Wang, Jiayin Wang, Emily B. Roarty, Waree Rinsurongkawong, Jeff Lewis, Jack A. Roth, Stephen G. Swisher, J. Jack Lee, John V. Heymach, Ignacio I. Wistuba, Neda Kalhor, Ling Yang, Xin Yi, P. Andrew Futreal, Bonnie S. Glisson, Xuefeng Xia, Jianjun Zhang, Jun Zhao
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (4): 892–901.
https://doi.org/10.1158/1078-0432.CCR-19-0556
Published: 14 February 2020
View article titled, The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine Carcinoma
Open the PDF for The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine Carcinoma in another window
Includes: Supplementary data
Journal Articles

Novel MYBL1 Gene Rearrangements with Recurrent MYBL1–NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations

Yoshitsugu Mitani, Bin Liu, Pulivarthi H. Rao, Vishnupriya J. Borra, Mark Zafereo, Randal S. Weber, Merrill Kies, Guillermina Lozano, P. Andrew Futreal, Carlos Caulin, Adel K. El-Naggar
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (3): 725–733.
https://doi.org/10.1158/1078-0432.CCR-15-2867-T
Published: 31 January 2016
View article titled, Novel <em>MYBL1</em> Gene Rearrangements with Recurrent <em>MYBL1–NFIB</em> Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations
Open the PDF for Novel <em>MYBL1</em> Gene Rearrangements with Recurrent <em>MYBL1–NFIB</em> Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations in another window
Includes: Supplementary data
Journal Articles

Novel Chromosomal Rearrangements and Break Points at the t(6;9) in Salivary Adenoid Cystic Carcinoma: Association with MYB–NFIB Chimeric Fusion, MYB Expression, and Clinical Outcome

Yoshitsugu Mitani, Pulivarthi H. Rao, P. Andrew Futreal, Dianna B. Roberts, Philip J. Stephens, Yi-Jue Zhao, Li Zhang, Mutsumi Mitani, Randal S. Weber, Scott M. Lippman, Carlos Caulin, Adel K. El-Naggar
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (22): 7003–7014.
https://doi.org/10.1158/1078-0432.CCR-11-1870
Published: 14 November 2011
View article titled, Novel Chromosomal Rearrangements and Break Points at the t(6;9) in Salivary Adenoid Cystic Carcinoma: Association with <em>MYB</em>–<em>NFIB</em> Chimeric Fusion, <em>MYB</em> Expression, and Clinical Outcome
Open the PDF for Novel Chromosomal Rearrangements and Break Points at the t(6;9) in Salivary Adenoid Cystic Carcinoma: Association with <em>MYB</em>–<em>NFIB</em> Chimeric Fusion, <em>MYB</em> Expression, and Clinical Outcome in another window
Includes: Supplementary data
Journal Articles

Loss of the Mismatch Repair Protein MSH6 in Human Glioblastomas Is Associated with Tumor Progression during Temozolomide Treatment

Daniel P. Cahill, Kymberly K. Levine, Rebecca A. Betensky, Patrick J. Codd, Candice A. Romany, Linsey B. Reavie, Tracy T. Batchelor, P. Andrew Futreal, Michael R. Stratton, William T. Curry, A. John Iafrate, David N. Louis
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (7): 2038–2045.
https://doi.org/10.1158/1078-0432.CCR-06-2149
Published: 02 April 2007
View article titled, Loss of the Mismatch Repair Protein MSH6 in Human Glioblastomas Is Associated with Tumor Progression during Temozolomide Treatment
Open the PDF for Loss of the Mismatch Repair Protein MSH6 in Human Glioblastomas Is Associated with Tumor Progression during Temozolomide Treatment in another window
Includes: Supplementary data
Journal Articles

The Pathology of Familial Breast Cancer: Histological Features of Cancers in Families Not Attributable to Mutations in BRCA1 or BRCA2

Sunil R. Lakhani, Barry A. Gusterson, Jocelyne Jacquemier, John P. Sloane, Thomas J. Anderson, Marc J. van de Vijver, Deon Venter, Alex Freeman, Antonios Antoniou, Lesley McGuffog, Elizabeth Smyth, C. Michael Steel, Neva Haites, Rodney J. Scott, David Goldgar, Susan Neuhausen, Peter A. Daly, Wilma Ormiston, Ross McManus, Siegfried Scherneck, Bruce A. J. Ponder, P. Andrew Futreal, Julian Peto, Dominique Stoppa-Lyonnet, Yves-Jean Bignon, Jeffery P. Struewing, D. Timothy Bishop, J. G. M. Klijn, Peter Devilee, Cees J. Cornelisse, Christine Lasset, Gilbert Lenoir, Rosa Bjork Barkardottir, Valgardur Egilsson, Ute Hamann, Jenny Chang-Claude, Hagay Sobol, Barbara Weber, Douglas F. Easton, Michael R. Stratton
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (3): 782–789.
Published: 01 March 2000
View article titled, The Pathology of Familial Breast Cancer: Histological Features of Cancers in Families Not Attributable to Mutations in <em>BRCA1</em> or <em>BRCA2</em>
Open the PDF for The Pathology of Familial Breast Cancer: Histological Features of Cancers in Families Not Attributable to Mutations in <em>BRCA1</em> or <em>BRCA2</em> in another window